Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Equity Average (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Equity Average for 15 consecutive years, with $3.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average rose 24.76% to $3.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.9 million, a 24.76% increase, with the full-year FY2024 number at $5.4 million, down 66.59% from a year prior.
  • Equity Average was $3.9 million for Q3 2025 at GeoVax Labs, down from $5.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $29.8 million in Q3 2022 to a low of -$1.1 million in Q2 2024.
  • A 5-year average of $12.9 million and a median of $11.2 million in 2021 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: surged 1180.0% in 2021, then crashed 105.63% in 2024.
  • GeoVax Labs' Equity Average stood at $11.2 million in 2021, then soared by 161.03% to $29.2 million in 2022, then plummeted by 74.51% to $7.4 million in 2023, then dropped by 8.94% to $6.8 million in 2024, then crashed by 42.97% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Equity Average are $3.9 million (Q3 2025), $5.4 million (Q2 2025), and $6.5 million (Q1 2025).